UTSA COS Summer Research Experience for 2013
Biomarker Discovery in Glucocorticoid Resistance in EAE
Dr. Forsthuber is addressing the urgent need for biomarkers to monitor and optimize clinical efficacy of glucocorticoid (GC) treatment and to help better understand the mechanisms underlying GC resistance. His project seeks to identify biomarkers for GC treatment efficacy and GC-resistance in multiple sclerosis that will provide information on the mechanism(s) underlying GC-resistance in autoimmune diseases.
» return
Funding provided by:
